Showing 1 - 2 results of 2 for search 'Irene Helenowski', query time: 0.01s Refine Results
  1. 1
    Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer

    Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer by Ami N Shah, Lisa Flaum, Irene Helenowski, Cesar A Santa-Maria, Sarika Jain, Alfred Rademaker, Valerie Nelson, Dean Tsarwhas, Massimo Cristofanilli, William Gradishar

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors

    Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland T... by Young Kwang Chae, Richard Duan, Liam Il‐Young Chung, Youjin Oh, Borislav Alexiev, Sangwon Shin, Sukjun Kim, Irene Helenowski, Maria Matsangou, Victoria Villaflor, Devalingam Mahalingam

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: